Hummingbird Diagnostics

Hummingbird Diagnostics GmbH is leveraging the predictive power of blood-borne miRNA to provide insights into human health and disease. The analysis of miRNA using the Hummingbird platform holds potential for early disease detection, disease-specific prognosis, treatment response prediction, and patient-centered therapy development. Hummingbird Diagnostics GmbH develops novel miRNA diagnostic technologies to improve human health. Hummingbird Diagnostics GmbH possesses top-tier expertise in handling and analyzing blood-borne miRNA, evaluating immune system responses to diseases, and has a strong track record in molecular diagnostics, clinical laboratory science, computational biology, as well as statistical machine learning and artificial intelligence.